Phase II Study - Trial of a Phototherapy Light Device to Improve Sleep Health (PHOTONS)
2021年11月1日 更新者:MICHAEL A GRANDNER、University of Arizona
There are few devices currently on the market claiming to improve sleep.
This study will investigate the efficacy of phototherapy on improving sleep, in the form of a wearable neck device used at night.
研究概览
详细说明
This study will investigate the efficacy of phototherapy on improving sleep, in the form of a wearable neck device used at night.
Phototherapy has been shown to improve chronic pain, cerebral blood flow, neurological function, and capillary growth in skeletal muscle.
A device worn at night may improve sleep onset, total sleep time, or modify sleep architecture.
Improved cardiovascular function may facilitate a decrease in core body temperature needed for sleep onset.
Relaxation from direct heat may help to decrease cortisol levels, thus reducing the number of night-time arousals.
It may also decrease circulating levels of norepinephrine (NE), one of the main neurotransmitters involved in arousal.
The aim of this study is to evaluate if the device worn leads to greater next-day wellbeing and cognitive function as a result of increased slow-wave activity.
研究类型
介入性
注册 (预期的)
30
阶段
- 阶段2
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Arizona
-
Tucson、Arizona、美国、85719
- 招聘中
- Department of Psychiatry, University of Arizona
-
接触:
- Michael A Grandner, PhD
- 电话号码:520-626-6246
- 邮箱:grandner@email.arizona.edu
-
接触:
- Chloe CA Wills
- 电话号码:520 626 1737
- 邮箱:chloecawills@psychiatry.arizona.edu
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
30年 至 60年 (成人)
接受健康志愿者
是的
有资格学习的性别
全部
描述
Inclusion Criteria:
- Between the ages of 18 and 60 years old
- Able to read and write fluently in English
- Access to a mobile device for video calls, online questionnaires, syncing devices, and communication with study staff
- Access to a residential mailing address for shipping study materials
- Exhibit a score of >8 on the Insomnia Severity Index
- Self-report that they have a problem with their sleep that they wish to improve
Exclusion Criteria:
- Have a moderate to severe current sleep disorder
- Have a current psychiatric disorder
- Are taking medication that would interfere with sleep, including beta blockers, antidepressants, antianxiety medications, hypnotics, or stimulants
- Have a medical condition that would interfere with their ability to complete all study procedures or would render measurements invalid (e.g., some autoimmune conditions, cardiac conditions, endocrine conditions, or chronic pain conditions)
- Exhibit a regular sleep schedule, where bed and wake times are kept within a 2-hour window 7 days per week
- Exhibit a regular sleep schedule during the night, beginning no earlier than 9pm and ending no later than 10am
- Have not engaged in shift work for the past month, and will refrain from shift work during the study
- Are unable to restrict alcohol consumption to no more than 2 drinks within 4 hours of sleep
- Are unable to restrict caffeine use to no coffee or caffeinated beverages after 12pm during the study
- Regularly smoke or use other tobacco products
- Regularly use cannabis-derived medicinal products
- Are pregnant
- Are a full-time caregiver to an individual that requires attending during the evening and night
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
有源比较器:Active
An active phototherapy device
|
The active phototherapy device will emit light
|
假比较器:Sham (Placebo)
An inactive device
|
The active phototherapy device will emit light
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Change in subjective rating of the device across a 3-week intervention
大体时间:Change in subjective rating of the device from baseline (pre; Day 0) to after 21 days of wearing it (post)
|
There will be a subjective rating of the phototherapy device using a series of questions assessing device's effect on sleep and next-day function at the end of the trial.
|
Change in subjective rating of the device from baseline (pre; Day 0) to after 21 days of wearing it (post)
|
Change in Insomnia Severity Index (ISI) scores across a 3-week intervention
大体时间:Change from baseline over the course of the study (after 21 days of wearing the device)
|
The ISI is a 7-item insomnia screening tool that is the gold standard for quantifying severity of clinical insomnia symptoms.
|
Change from baseline over the course of the study (after 21 days of wearing the device)
|
Change in objective sleep efficiency across a 3-week intervention
大体时间:Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Objective sleep efficiency will be measured with a wearable device (Oura ring) that is worn for the duration of the study and captures sleep and wake data using actigraphy.
|
Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Change in mean sleep latency assessed using sleep diaries
大体时间:Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Sleep latency, or time taken to fall asleep, will be assessed using morning sleep diaries completed by the participant upon awakening.
The mean sleep latency during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).
|
Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Change in Karolinska Sleepiness Scale (KSS) score
大体时间:Change from before intervention (pre) to post three weeks of wearing the phototherapy device (Day 21)..
|
The Karolinska Sleepiness Scale (KSS) measures situational sleepiness on a 9-point scale
|
Change from before intervention (pre) to post three weeks of wearing the phototherapy device (Day 21)..
|
Circadian Energy Scale (CIRENS) score
大体时间:Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
CIRENS is a very short and simple chronotype measurement tool based on energy.
The CIRENS consists of two introspective questions about the usual energy level (very low, low, moderate, high, or very high, scored 1 to 5) in the morning and in the evening.
The difference between energy level scores (-4 to 4) felt by respondents in the evening and morning defines the chronotype score and classification.
|
Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
Positive and Negative Affect Scales (PANAS) Positive Affect
大体时间:Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
The Positive and Negative Affect Scales are brief screening measures that assess both positive and negative emotional experiences.
This scale will allow for separate assessment of impact on positive mood.
|
Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
Positive and Negative Affect Scales (PANAS) Negative Affect
大体时间:Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
The Positive and Negative Affect Scales are brief screening measures that assess both positive and negative emotional experiences.
This scale will allow for separate assessment of impact on negative mood.
|
Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
Change in Fatigue Severity Scale (FSS) across a three-week intervention
大体时间:Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
Fatigue Severity Scale (FSS) is a well-validated 9-item clinical measure that assesses overall levels of mental and physical fatigue, with answers ranging from 1- "Strongly Disagree" to 7-"Strongly Agree".
|
Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
Change in Profile of Mood States (POMS) across a three week intervention
大体时间:Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
The Profile of Mood States (POMS) is a psychological rating scale used to assess transient, distinct mood states.
The POMS measures six different dimensions of mood swings over a period of time.
These include: Tension or Anxiety, Anger or Hostility, Vigor or Activity, Fatigue or Inertia, Depression or Dejection, Confusion or Bewilderment.
A total score will be evaluated in addition to the individual items.
|
Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).
|
Change in Wake After Sleep Onset (WASO) assessed using morning sleep diaries over the duration of the study
大体时间:Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Wake after sleep onset (WASO), or the number of nocturnal awakenings, will be assessed using morning sleep diaries completed by the participant upon awakening.
The mean WASO during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).
|
Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Change in sleep efficiency assessed using morning sleep diaries over the duration of the study
大体时间:Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Sleep efficiency, or the amount of time spent asleep during a sleep opportunity, will be assessed using morning sleep diaries completed by the participant upon awakening.
The mean sleep efficiency during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).
|
Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Change in total sleep time assessed using morning sleep diaries over the duration of the study
大体时间:Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Total sleep time will be assessed using morning sleep diaries completed by the participant upon awakening.
The mean total sleep time during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).
|
Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Change in morning refreshed feeling assessed using morning sleep diaries over the duration of the study
大体时间:Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
Morning refreshed feeling will be assessed using morning sleep diaries completed by the participant upon awakening.
The mean refreshed feeling during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).
|
Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
合作者
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2021年9月2日
初级完成 (预期的)
2022年1月30日
研究完成 (预期的)
2022年1月30日
研究注册日期
首次提交
2021年11月1日
首先提交符合 QC 标准的
2021年11月1日
首次发布 (实际的)
2021年11月11日
研究记录更新
最后更新发布 (实际的)
2021年11月11日
上次提交的符合 QC 标准的更新
2021年11月1日
最后验证
2021年11月1日
更多信息
与本研究相关的术语
其他研究编号
- 2012256803
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
未定
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
Phototherapy device的临床试验
-
St. Louis UniversityLucerno Dynamics Limited Liability Company (LLC)完全的
-
University Hospital, Basel, SwitzerlandClinical Trial Unit, University Hospital Basel, Switzerland完全的
-
Taipei Veterans General Hospital, TaiwanLotung Poh-Ai Hospital未知